Impact of Policy Adjustments on Telehealth Fraud
On May 19, 2021, the Medicare Payment Advisory Commission (MedPac) provided feedback to Congress regarding their opinions on the effectiveness of the overwhelming 200 healthcare policy changes that Congress and CMS instituted during the interval of January through July 2020, in response to the coronavirus public health emergency. Aside from the obvious and necessary benefits of these changes in response to the pandemic, MedPac raises concerns about the detrimental impact in the realm of fraud in healthcare: “…not all actors in the healthcare system are well-intentioned”.
Impact of the COVID-19 Pandemic on Healthcare Fraud
During the pandemic, healthcare claim fraud prevails as new fraud schemes develop and adapt to the changes in healthcare guidelines enacted, so providers can continue to treat patients. Two major areas of FWA expansion during the pandemic include Telehealth and COVID-19-related laboratory testing add-on services.
Effective dates now known for Pfizer and Moderna vaccines, AstraZeneca vaccine coming
Pfizer and Moderna Covid vaccine codes receive effective dates, AstraZeneca vaccine assigned procedure codes but not yet effective.